Taken together, the data suggest convergence of the dual mode of regulation at SGK1 in response to progesterone treatment, along with up-regulation of NDRG1 in multiple breast cancer cell lines independent of their PR status. The gene discussed is NDRG1; the disease is breast carcinoma.